HIV drug resistance surveys: tool for data entry

Overview

 Nationally representative surveillance of pre-treatment HIV drug resistance (PDR) in populations initiating antiretroviral therapy (ART) is critical to inform the selection of effective first-line ART, as well as appropriate regimens for pre-exposure prophylaxis and post-exposure prophylaxis. Similarly, nationally representative surveillance of acquired HIV drug resistance (ADR) among populations failing ART provides critical information to assess programme efforts to maximize viral suppression, to inform selection and management of second-line therapies and to gauge the extent to which patients are switching therapies unnecessarily. WHO recommends that countries routinely conduct national surveys of PDR and ADR.

To facilitate data collection at sites participating in PDR and ADR surveys, WHO has developed Excel-based Site- level Entry Tools. In addition, to support the management, analysis and reporting of national data, WHO has developed National Data Consolidator Tools for PDR and ADR surveys.

These tools aggregate data from multiple Site-level Data Entry Tools into one national file. This manual provides instructions for using the PDR and ADR Site-level Data Entry Tools and the PDR and ADR National Data Consolidator Tools.